Lupin rises as its arm receives USFDA approval for Generic LYRICA capsules

05 Jul 2012 Evaluate

Lupin is currently trading at Rs. 540.00, up by 2.10 points or 0.39% from its previous closing of Rs. 537.90 on the BSE.

The scrip opened at Rs. 539.40 and has touched a high and low of Rs. 544.00 and Rs. 537.55 respectively. So far 32,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 574.05 on 17-Apr-2012 and a 52 week low of Rs. 409.50 on 14-Dec-2011.

Last one week high and low of the scrip stood at Rs. 547.80 and Rs. 534.00 respectively. The current market cap of the company is Rs. 24,119 crore.

The promoters holding in the company stood at 46.93% while Institutions and Non-Institutions held 44.05% and 9.02% respectively.

Lupin’s subsidiary - Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its Pergabalin capsules, 0.25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg from United States Food Drugs Administration (FDA) to market a generic version of CP Pharmaceuticals C.V.LYRICA (Pregabalin) capsules.

Lupin's Pergabalin capsules 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg are the AB-rated generic equivalent of LYRICA capsules, which is indicated for neuropathic pain associated with diabetic peripheral neuropathy, post herpetic neuralgia, adjunctive therapy for Adult patients with partial onset seizures and fibromyalgia. LYRICA capsules had annual US sales of approximately $1.8 billion for the twelve months ending March 2012, as per IMS Health sales data.

Lupin has a vibrant presence in the Indian pharmaceuticals market and has over the past several years made major strides in expanding its therapy portfolio. The company has a robust promotion and distribution setup along with a strong presence in various therapeutic areas, including the fast growing diabetes market.

Lupin Share Price

2112.95 3.95 (0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×